Related News
Scholarly Project Profile: Samhita (Sami) Vedula
Wednesday, March 22, 2023
Scholarly Project Profile: Michael Olson
Monday, March 20, 2023
Scholarly Project Profile: Patrick Mayolo
Friday, March 17, 2023News 4 Tucson
The University of Arizona College of Medicine – Phoenix and other public health and safety agencies want to warn Arizona health care providers about the risks of licit drugs being contaminated with xylazine, which can put user into coma or cause respiratory failure.
"Xylazine is a very powerful veterinary tranquilizer that has been increasingly identified as an adulterant in street drugs, and at autopsy in drug-related deaths across Arizona," said Daniel Brooks, MD, clinical professor of Internal Medicine and co-director of the Center for Toxicology and Pharmacology Education and Research. "We are working with public health and safety agencies to warn Arizona healthcare providers and medical examiners about this dangerous drug."
About the College
Founded in 2007, the University of Arizona College of Medicine – Phoenix inspires and trains exemplary physicians, scientists and leaders to optimize health and health care in Arizona and beyond. By cultivating collaborative research locally and globally, the college accelerates discovery in a number of critical areas — including cancer, stroke, traumatic brain injury and cardiovascular disease. Championed as a student-centric campus, the college has graduated 745 physicians, all of whom received exceptional training from nine clinical partners and more than 2,600 diverse faculty members. As the anchor to the Phoenix Bioscience Core, which is projected to have an economic impact of $3.1 billion by 2025, the college prides itself on engaging with the community, fostering education, inclusion, access and advocacy.